667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 85,420 shares at $73.83 ($6.3M) on 2018-12-10, disclosed to the SEC on 2018-12-12.
Open-market sale of $6.3M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.83 | 9 | $664 | 0.0% |
| 2 | $73.83 | 204 | $15K | 0.2% |
| 3 | $73.83 | 1,185 | $87K | 1.4% |
| 4 | $73.83 | 7,718 | $570K | 9.0% |
| 5 | $73.83 | 118 | $9K | 0.1% |
| 6 | $73.83 | 132 |
| $10K |
| 0.2% |
| 7 | $71.81 | 15 | $1K | 0.0% |
| 8 | $71.81 | 334 | $24K | 0.4% |
| 9 | $71.81 | 1,939 | $139K | 2.2% |
| 10 | $71.81 | 194 | $14K | 0.2% |
| 11 | $71.81 | 12,627 | $907K | 14.4% |
| 12 | $71.81 | 216 | $16K | 0.2% |
| 13 | $74.88 | 597 | $45K | 0.7% |
| 14 | $74.88 | 41 | $3K | 0.0% |
| 15 | $74.88 | 534 | $40K | 0.6% |
| 16 | $74.88 | 921 | $69K | 1.1% |
| 17 | $74.88 | 5,342 | $400K | 6.3% |
| 18 | $74.88 | 34,794 | $2.6M | 41.3% |
| 19 | $73.09 | 18 | $1K | 0.0% |
| 20 | $73.09 | 234 | $17K | 0.3% |
| 21 | $73.09 | 262 | $19K | 0.3% |
| 22 | $73.09 | 403 | $29K | 0.5% |
| 23 | $73.09 | 2,340 | $171K | 2.7% |
| 24 | $73.09 | 15,243 | $1.1M | 17.7% |
| Total | $73.83 avg | 85,420 | $6.3M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |